Vimarsana
Biggest News Aggregation in the World

Page 14 - Alpha Da News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpha Da Today - Breaking & Trending Today

Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT - Vimarsana News

Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT

JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative...

Israeli Tech and Innovation News - Vimarsana News

Israeli Tech and Innovation News

Patient, 60, is given alpha-radiation to target the tumor without harming healthy tissue in ‘historical’ procedure

Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™ - Vimarsana News

Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced...

Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site - Vimarsana News

Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC - Vimarsana News

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy...